Skip to main content
Top
Published in: BMC Public Health 1/2016

Open Access 01-12-2016 | Research article

The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort

Authors: Elena Raffetti, Maria Concetta Postorino, Francesco Castelli, Salvatore Casari, Filippo Castelnuovo, Franco Maggiolo, Elisa Di Filippo, Alessandro D’Avino, Andrea Gori, Nicoletta Ladisa, Massimo Di Pietro, Laura Sighinolfi, Fabio Zacchi, Carlo Torti

Published in: BMC Public Health | Issue 1/2016

Login to get access

Abstract

Background

We aimed at evaluating frequency and factors associated with late presentation and advanced HIV disease and excess risk of death due to these conditions from 1985 to 2013 among naïve HIV infected patients enrolled in the Italian MASTER Cohort.

Methods

All antiretroviral naive adults with available CD4+ T cell count after diagnosis of HIV infection were included. Multivariable logistic regression analysis investigated factors associated either with late presentation or advanced HIV disease. Probabilities of survival were estimated both at year-1 and at year-5 according to the Kaplan-Meier method. Flexible parametric models were used to evaluate changes in risk of death overtime according to late presentation and advanced HIV disease. The analyses were stratified for calendar periods.

Results

19,391 patients were included (54 % were late presenters and 37.6 % were advanced presenters). At multivariable analysis, the following factors were positively associated with late presentation: male gender (OR = 1.29), older age (≥55 years vs. <25 years; OR = 7.45), migration (OR = 1.54), and heterosexual risk factor for HIV acquisition (OR = 1.52) or IDU (OR = 1.27) compared to homosexual risk. Survival rates at year-5 increased steadily and reached 92.1 % for late presenters vs. 97.4 % for non-late presenters enrolled in the period 2004–2009. Using flexible parametric models we found a sustained reduction of hazard ratios over time for any cause deaths between late and non-late presenters over time. Similar results were found for advanced HIV disease.

Conclusion

Screening polices need to be urgently implemented, particularly in most-at-risk categories for late presentation, such as migrants, older patients and those with heterosexual intercourse or IDU as risk factors for HIV acquisition. Although in recent years the impact of late presentation on survival decreased, about 10 % of patients diagnosed in more recent years remains at increased risk of death over a long-term follow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mocroft A, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510.CrossRefPubMedPubMedCentral Mocroft A, et al. Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med. 2013;10(9):e1001510.CrossRefPubMedPubMedCentral
2.
go back to reference Antinori A, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.CrossRefPubMed Antinori A, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 2011;12(1):61–4.CrossRefPubMed
3.
go back to reference Mocroft A., et al., Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47):7–18. Mocroft A., et al., Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. 2015;20(47):7–18.
5.
go back to reference Sabin CA, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18(16):2145–51.CrossRefPubMed Sabin CA, et al. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. AIDS. 2004;18(16):2145–51.CrossRefPubMed
6.
go back to reference Sabin CA, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006;20(1):67–71.CrossRefPubMed Sabin CA, et al. Deaths in the era of HAART: contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers. AIDS. 2006;20(1):67–71.CrossRefPubMed
7.
go back to reference Sabin CA, et al. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS. 2010;24(5):723–7.PubMed Sabin CA, et al. Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS. 2010;24(5):723–7.PubMed
8.
go back to reference Celesia BM, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. Eur Rev Med Pharmacol Sci. 2013;17(16):2218–24.PubMed Celesia BM, et al. Late presentation of HIV infection: predictors of delayed diagnosis and survival in Eastern Sicily. Eur Rev Med Pharmacol Sci. 2013;17(16):2218–24.PubMed
9.
10.
go back to reference Iwuji CC, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013;14:230.CrossRefPubMedPubMedCentral Iwuji CC, et al. Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial. Trials. 2013;14:230.CrossRefPubMedPubMedCentral
12.
go back to reference Moore DM, et al. HIV Community Viral Load and Factors Associated With Elevated Viremia Among a Community-Based Sample of Men Who Have Sex With Men in Vancouver, Canada. J Acquir Immune Defic Syndr. 2016;72(1):87–95.CrossRefPubMed Moore DM, et al. HIV Community Viral Load and Factors Associated With Elevated Viremia Among a Community-Based Sample of Men Who Have Sex With Men in Vancouver, Canada. J Acquir Immune Defic Syndr. 2016;72(1):87–95.CrossRefPubMed
13.
go back to reference Wood E, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.CrossRefPubMedPubMedCentral Wood E, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.CrossRefPubMedPubMedCentral
16.
go back to reference Camoni L, et al. The continued ageing of people with AIDS in Italy: recent trend from the national AIDS Registry. Ann Ist Super Sanita. 2014;50(3):291–7.PubMed Camoni L, et al. The continued ageing of people with AIDS in Italy: recent trend from the national AIDS Registry. Ann Ist Super Sanita. 2014;50(3):291–7.PubMed
17.
go back to reference Hall HI, et al. Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison. PLoS One. 2013;8(11):e77763.CrossRefPubMedPubMedCentral Hall HI, et al. Late diagnosis and entry to care after diagnosis of human immunodeficiency virus infection: a country comparison. PLoS One. 2013;8(11):e77763.CrossRefPubMedPubMedCentral
18.
go back to reference Girardi E, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36(4):951–9.CrossRefPubMed Girardi E, et al. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. J Acquir Immune Defic Syndr. 2004;36(4):951–9.CrossRefPubMed
19.
go back to reference d’Arminio Monforte A, et al. Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther. 2011;16(7):1103–12.CrossRefPubMed d’Arminio Monforte A, et al. Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther. 2011;16(7):1103–12.CrossRefPubMed
20.
go back to reference Borghi V, et al. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49(3):282–6.CrossRefPubMed Borghi V, et al. Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr. 2008;49(3):282–6.CrossRefPubMed
21.
go back to reference Loconsole D, et al. Surveillance of new HIV infections/diagnoses in Puglia region (south Italy), years 2007–2011. Ann Ig. 2013;25(4):291–8.PubMed Loconsole D, et al. Surveillance of new HIV infections/diagnoses in Puglia region (south Italy), years 2007–2011. Ann Ig. 2013;25(4):291–8.PubMed
22.
go back to reference Torti C., et al. Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). Int J Epidemiol. 2015. [Epub ahead of print] Torti C., et al. Cohort Profile: Standardized Management of Antiretroviral Therapy Cohort (MASTER Cohort). Int J Epidemiol. 2015. [Epub ahead of print]
23.
go back to reference Lambert P. Further development of flexible parametric models for survival analysis. The Stata J. 2009;9(2):265–90. Lambert P. Further development of flexible parametric models for survival analysis. The Stata J. 2009;9(2):265–90.
24.
go back to reference Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175–97.CrossRefPubMed Royston P, Parmar MK. Flexible parametric proportional-hazards and proportional-odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects. Stat Med. 2002;21(15):2175–97.CrossRefPubMed
25.
go back to reference Lambert PC, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol. 2011;35(6):526–33.CrossRefPubMed Lambert PC, et al. Quantifying differences in breast cancer survival between England and Norway. Cancer Epidemiol. 2011;35(6):526–33.CrossRefPubMed
26.
go back to reference Zoufaly A, et al. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13(3):172–81.CrossRefPubMed Zoufaly A, et al. Late presentation for HIV diagnosis and care in Germany. HIV Med. 2012;13(3):172–81.CrossRefPubMed
27.
go back to reference Vives N, et al. Factors associated with late presentation of HIV infection in Catalonia, Spain. Int J STD AIDS. 2012;23(7):475–80.CrossRefPubMed Vives N, et al. Factors associated with late presentation of HIV infection in Catalonia, Spain. Int J STD AIDS. 2012;23(7):475–80.CrossRefPubMed
28.
go back to reference Helleberg M, et al. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis. 2012;44(4):282–8.CrossRefPubMed Helleberg M, et al. Late presenters, repeated testing, and missed opportunities in a Danish nationwide HIV cohort. Scand J Infect Dis. 2012;44(4):282–8.CrossRefPubMed
29.
go back to reference Ndiaye B, et al. Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997–2007. BMC Infect Dis. 2011;11:11.CrossRefPubMedPubMedCentral Ndiaye B, et al. Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997–2007. BMC Infect Dis. 2011;11:11.CrossRefPubMedPubMedCentral
30.
go back to reference Sulis G, et al. Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010. Infection. 2014;42(5):859–67.CrossRefPubMed Sulis G, et al. Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000–2010. Infection. 2014;42(5):859–67.CrossRefPubMed
31.
go back to reference Yombi JC, et al. Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre. Acta Clin Belg. 2014;69(1):33–9.CrossRefPubMed Yombi JC, et al. Late presentation for human immunodeficiency virus HIV diagnosis results of a Belgian single centre. Acta Clin Belg. 2014;69(1):33–9.CrossRefPubMed
34.
go back to reference Grov C, et al. Men who have sex with mens’ exposure to, use of, and subjective experiences with the ’NYC Condom’. AIDS Behav. 2014;18(11):2172–7.CrossRefPubMedPubMedCentral Grov C, et al. Men who have sex with mens’ exposure to, use of, and subjective experiences with the ’NYC Condom’. AIDS Behav. 2014;18(11):2172–7.CrossRefPubMedPubMedCentral
35.
go back to reference Hotton AL, et al. relationship dynamics and sexual risk reduction strategies among heterosexual young adults: a qualitative study of sexually transmitted infection clinic attendees at an urban Chicago health center. AIDS Patient Care STDs. 2015;29(12):668–74.CrossRefPubMedPubMedCentral Hotton AL, et al. relationship dynamics and sexual risk reduction strategies among heterosexual young adults: a qualitative study of sexually transmitted infection clinic attendees at an urban Chicago health center. AIDS Patient Care STDs. 2015;29(12):668–74.CrossRefPubMedPubMedCentral
36.
go back to reference Cruciani M, et al. Increasing prevalence of HIV infection among first time clients in Italian drug treatment services - is it sexual transmission? BMC Infect Dis. 2015;15(1):201.CrossRefPubMedPubMedCentral Cruciani M, et al. Increasing prevalence of HIV infection among first time clients in Italian drug treatment services - is it sexual transmission? BMC Infect Dis. 2015;15(1):201.CrossRefPubMedPubMedCentral
37.
go back to reference Lodi S, et al. Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. AIDS. 2014;28(15):2297–306.PubMed Lodi S, et al. Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord. AIDS. 2014;28(15):2297–306.PubMed
38.
go back to reference Sobrino-Vegas P, et al. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther. 2012;17(1):1–8.CrossRefPubMed Sobrino-Vegas P, et al. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther. 2012;17(1):1–8.CrossRefPubMed
39.
go back to reference CASCADE Collaboration. Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. HIV Med. 2000;1(4):224–31.CrossRef CASCADE Collaboration. Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE. HIV Med. 2000;1(4):224–31.CrossRef
40.
go back to reference The INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795–807. August 27, 2015.CrossRefPubMedCentral The INSIGHT START Study Group. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection. N Engl J Med. 2015;373:795–807. August 27, 2015.CrossRefPubMedCentral
Metadata
Title
The risk of late or advanced presentation of HIV infected patients is still high, associated factors evolve but impact on overall mortality is vanishing over calendar years: results from the Italian MASTER Cohort
Authors
Elena Raffetti
Maria Concetta Postorino
Francesco Castelli
Salvatore Casari
Filippo Castelnuovo
Franco Maggiolo
Elisa Di Filippo
Alessandro D’Avino
Andrea Gori
Nicoletta Ladisa
Massimo Di Pietro
Laura Sighinolfi
Fabio Zacchi
Carlo Torti
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2016
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-016-3477-z

Other articles of this Issue 1/2016

BMC Public Health 1/2016 Go to the issue